Identification and functional characterization of the phosphorylation sites of the neuropeptide FF2 receptor

Journal of Biological Chemistry

Volumn 289, Issue 49, 2014, Pages 33754-33766

  Bray, Lauriane ^a   Froment, Carine ^a   Pardo, Pierre ^a   Candotto, Cédric ^a   Burlet Schiltz, Odile ^a   Zajac, Jean Marie ^a   Mollereau, Catherine ^a   Moulédous, Lionel ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL SIGNALING; ENZYME ACTIVITY;

FUNCTIONAL CHARACTERIZATION; G PROTEIN COUPLED RECEPTORS; INFORMATION CONCERNING; MASS SPECTROMETRIC ANALYSIS; PHOSPHORYLATION SITES; POST-TRANSLATIONAL MODIFICATIONS; RECEPTOR SIGNALING; SITE DIRECTED MUTAGENESIS;

PHOSPHORYLATION;

BETA ARRESTIN 2; CALCIUM; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE FF; NEUROPEPTIDE FF2 RECEPTOR; SERINE; THREONINE; UNCLASSIFIED DRUG; NEUROPEPTIDE FF RECEPTOR; NEUROPEPTIDE RECEPTOR; OLIGOPEPTIDE; PHENYLALANYL-LEUCYL-PHENYLALANYL-GLUTAMINYL-PROLYL-GLUTAMINYL-ARGINYL-PHENYLALANINAMIDE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; DESENSITIZATION; HUMAN; IMMUNOCYTOCHEMISTRY; INTERNALIZATION; MASS SPECTROMETRY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RAT; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING; AMINO ACID SEQUENCE; CHEMISTRY; CYTOLOGY; GENETICS; KINETICS; METABOLISM; MOLECULAR GENETICS; NERVE CELL; PEPTIDE MAPPING; PHOSPHORYLATION; PROTEIN TRANSPORT; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEURONS; OLIGOPEPTIDES; PEPTIDE MAPPING; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; RECEPTORS, NEUROPEPTIDE; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

EID: 84916886215     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.612614     Document Type: Article

References (50)

1. Bonini, J. A., Jones, K. A., Adham, N., Forray, C., Artymyshyn, R., Durkin, M. M., Smith, K. E., Tamm, J. A., Boteju, L. W., Lakhlani, P. P., Raddatz, R., Yao, W. J., Ogozalek, K. L., Boyle, N., Kouranova, E. V., Quan, Y., Vaysse, P. J., Wetzel, J. M., Branchek, T. A., Gerald, C., and Borowsky, B. (2000) Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J. Biol. Chem. 275, 39324-39331
2. Elshourbagy, N. A., Ames, R. S., Fitzgerald, L. R., Foley, J. J., Chambers, J. K., Szekeres, P. G., Evans, N. A., Schmidt, D. B., Buckley, P. T., Dytko, G. M., Murdock, P. R., Milligan, G., Groarke, D. A., Tan, K. B., Shabon, U., Nuthulaganti, P., Wang, D. Y., Wilson, S., Bergsma, D. J., and Sarau, H. M. (2000) Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J. Biol. Chem. 275, 25965-25971
3. Zajac, J. M. (2001) Neuropeptide FF: new molecular insights. Trends Pharmacol. Sci. 22, 63
4. Panula, P., Aarnisalo, A. A., and Wasowicz, K. (1996) Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog. Neurobiol. 48, 461-487
5. Mollereau, C., Roumy, M., and Zajac, J. M. (2005) Opioid-modulating peptides: mechanisms of action. Curr. Top. Med. Chem. 5, 341-355
6. Moulédous, L., Mollereau, C., and Zajac, J. M. (2010) Opioid-modulating properties of the neuropeptide FF system. Biofactors 36, 423-429
7. Yang, H. Y., Tao, T., and Iadarola, M. J. (2008) Modulatory role of neuropeptide FF system in nociception and opiate analgesia. Neuropeptides 42, 1-18
8. Simonin, F., Schmitt, M., Laulin, J. P., Laboureyras, E., Jhamandas, J. H., MacTavish, D., Matifas, A., Mollereau, C., Laurent, P., Parmentier, M., Kieffer, B. L., Bourguignon, J. J., and Simonnet, G. (2006) RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc. Natl. Acad. Sci. U.S.A. 103, 466-471
9. Elhabazi, K., Trigo, J. M., Mollereau, C., Moulédous, L., Zajac, J. M., Bihel, F., Schmitt, M., Bourguignon, J. J., Meziane, H., Petit-Demoulière, B., Bockel, F., Maldonado, R., and Simonin, F. (2012) Involvement of neuropeptide FF receptors in neuroadaptative responses to acute and chronic opiate treatments. Br. J. Pharmacol. 165, 424-435
10. Kotani, M., Mollereau, C., Detheux, M., Le Poul, E., Brézillon, S., Vakili, J., Mazarguil, H., Vassart, G., Zajac, J. M., and Parmentier, M. (2001) Functional characterization of a human receptor for neuropeptide FF and related peptides. Br. J. Pharmacol. 133, 138-144
11. Mollereau, C., Zajac, J. M., and Roumy, M. (2007) Staurosporine differentiation of NPFF(2) receptor-transfected SH-SY5Y neuroblastoma cells induces selectivity of NPFF activity towards opioid receptors. Peptides 28, 1125-1128
12. Pertovaara, A., Ostergård, M., Ankö, M. L., Lehti-Koivunen, S., Brandt, A., Hong, W., Korpi, E. R., and Panula, P. (2005) RFamide-related peptides signal through the neuropeptide FF receptor and regulate pain-related responses in the rat. Neuroscience 134, 1023-1032
13. Mollereau, C., Roumy, M., and Zajac, J. M. (2011) Neuropeptide FF receptor modulates potassium currents in a dorsal root ganglion cell line. Pharmacol. Rep. 63, 1061-1065
14. Ankö, M. L., and Panula, P. (2006) Regulation of endogenous human NPFF2 receptor by neuropeptide FF in SK-N-MC neuroblastoma cell line. J. Neurochem. 96, 573-584
15. Chuang, T. T., Iacovelli, L., Sallese, M., and De Blasi, A. (1996) G proteincoupled receptors: heterologous regulation of homologous desensitization and its implications. Trends Pharmacol. Sci. 17, 416-421
16. Lohse, M. J. (1993) Molecular mechanisms of membrane receptor desensitization. Biochim. Biophys. Acta 1179, 171-188
17. Hüttenrauch, F., Pollok-Kopp, B., and Oppermann, M. (2005) G proteincoupled receptor kinases promote phosphorylation and β-arrestin-mediated internalization of CCR5 homo-and hetero-oligomers. J. Biol. Chem. 280, 37503-37515
18. Moulédous, L., Froment, C., Dauvillier, S., Burlet-Schiltz, O., Zajac, J. M., and Mollereau, C. (2012) GRK2-mediated trans-phosphorylation contributes to the loss of function of mu opioid receptors induced by neuropeptide FF (NPFF2) receptors. J. Biol. Chem. 287, 12736-12749
19. Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J., and Caron, M. G. (2004) Desensitization ofGprotein-coupled receptors and neuronal functions. Annu. Rev. Neurosci. 27, 107-144
20. Shenoy, S. K., and Lefkowitz, R. J. (2011) β-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol. Sci. 32, 521-533
21. Busillo, J. M., Armando, S., Sengupta, R., Meucci, O., Bouvier, M., and Benovic, J. L. (2010) Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling. J. Biol. Chem. 285, 7805-7817
22. Butcher, A. J., Prihandoko, R., Kong, K. C., McWilliams, P., Edwards, J. M., Bottrill, A., Mistry, S., and Tobin, A. B. (2011) Differential G-proteincoupled receptor phosphorylation provides evidence for a signaling bar code. J. Biol. Chem. 286, 11506-11518
23. Lau, E. K., Trester-Zedlitz, M., Trinidad, J. C., Kotowski, S. J., Krutchinsky, A. N., Burlingame, A. L., and von Zastrow, M. (2011) Quantitative encoding of the effect of a partial agonist on individual opioid receptors by multisite phosphorylation and threshold detection. Sci. Signal 4, ra52
24. Nobles, K. N., Xiao, K., Ahn, S., Shukla, A. K., Lam, C. M., Rajagopal, S., Strachan, R. T., Huang, T. Y., Bressler, E. A., Hara, M. R., Shenoy, S. K., Gygi, S. P., and Lefkowitz, R. J. (2011) Distinct phosphorylation sites on the β2-adrenergic receptor establish a barcode that encodes differential functions of β-arrestin. Sci. Signal. 4, ra51
25. Liggett, S. B. (2011) Phosphorylation barcoding as a mechanism of directing GPCR signaling. Sci. Signal. 4, pe36
26. Tobin, A. B., Butcher, A. J., and Kong, K. C. (2008) Location, location, location: site-specific GPCR phosphorylation offers a mechanism for celltype-specific signalling. Trends Pharmacol. Sci. 29, 413-420
27. Gluck, L., Loktev, A., Mouledous, L., Mollereau, C., Law, P. Y., and Schulz, S. (2014) Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5. Biol. Psychiatry 2014, pii
28. Gicquel, S., Mazarguil, H., Allard, M., Simonnet, G., and Zajac, J. M. (1992) Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur. J. Pharmacol. 222, 61-67
29. Talmont, F., Garcia, L. P., Mazarguil, H., Zajac, J. M., and Mollereau, C. (2009) Characterization of two novel tritiated radioligands for labelling Neuropeptide FF (NPFF1 and NPFF2) receptors. Neurochem. Int. 55, 815-819
30. Moulédous, L., Merker, S., Neasta, J., Roux, B., Zajac, J. M., and Mollereau, C. (2008) Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells. Biochem. Biophys. Res. Commun. 373, 80-84
31. Mollereau, C., Mazarguil, H., Zajac, J. M., and Roumy, M. (2005) Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells. Mol. Pharmacol. 67, 965-975
32. Taus, T., Köcher, T., Pichler, P., Paschke, C., Schmidt, A., Henrich, C., and Mechtler, K. (2011) Universal and confident phosphorylation site localization using phosphoRS. J. Proteome Res. 10, 5354-5362
33. Gautier, V., Mouton-Barbosa, E., Bouyssié, D., Delcourt, N., Beau, M., Girard, J. P., Cayrol, C., Burlet-Schiltz, O., Monsarrat, B., and Gonzalez de Peredo, A. (2012) Label-free quantification and shotgun analysis of complex proteomes by one-dimensional SDS-PAGE/NanoLC-MS: evaluation for the large scale analysis of inflammatory human endothelial cells. Mol. Cell. Proteomics 11, 527-539
34. Xue, Y., Ren, J., Gao, X., Jin, C., Wen, L., and Yao, X. (2008) GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy. Mol. Cell. Proteomics 7, 1598-1608
35. Mollereau, C., Mazarguil, H., Marcus, D., Quelven, I., Kotani, M., Lannoy, V., Dumont, Y., Quirion, R., Detheux, M., Parmentier, M., and Zajac, J. M. (2002) Pharmacological characterization of human NPFF1 and NPFF2 receptors expressed in CHO cells by using NPY Y1 receptor antagonists. Eur. J. Pharmacol. 451, 245-256
36. Talmont, F., Moulédous, L., Piedra-Garcia, L., Schmitt, M., Bihel, F., Bourguignon, J. J., Zajac, J. M., and Mollereau, C. (2010) Pharmacological characterization of the mouse NPFF2 receptor. Peptides 31, 215-220
37. Maletínská, L., Tichá, A., Nagelová, V., Spolcová, A., Blechová, M., Elbert, T., and Zelezná, B. (2013) Neuropeptide FF analog RF9 is not an antagonist of NPFF receptor and decreases food intake in mice after its central and peripheral administration. Brain Res. 1498, 33-40
38. Sun, Y. L., Zhang, X. Y., He, N., Sun, T., Zhuang, Y., Fang, Q., Wang, K. R., and Wang, R. (2012) Neuropeptide FF activates ERK and NF kappa B signal pathways in differentiated SH-SY5Y cells. Peptides 38, 110-117
39. DeWire, S. M., Ahn, S., Lefkowitz, R. J., and Shenoy, S. K. (2007) β-Arrestins and cell signaling. Annu. Rev. Physiol. 69, 483-510
40. Asai, D., Toita, R., Murata, M., Katayama, Y., Nakashima, H., and Kang, J. H. (2014) Peptide substrates for G protein-coupled receptor kinase 2. FEBS Lett. 588, 2129-2132
41. Pronin, A. N., and Benovic, J. L. (1997) Regulation of the G protein-coupled receptor kinase GRK5 by protein kinase C. J. Biol. Chem. 272, 3806-3812
42. Singh, V., Raghuwanshi, S. K., Smith, N., Rivers, E. J., and Richardson, R. M. (2014) G protein-coupled receptor kinase-6 interacts with activator of G protein signaling-3 to regulate CXCR2-mediated cellular functions. J. Immunol. 192, 2186-2194
43. Daaka, Y., Pitcher, J. A., Richardson, M., Stoffel, R. H., Robishaw, J. D., and Lefkowitz, R. J. (1997) Receptor and Gβγ isoform-specific interactions with G protein-coupled receptor kinases. Proc. Natl. Acad. Sci. U.S.A. 94, 2180-2185
44. Celver, J., Xu, M., Jin, W., Lowe, J., and Chavkin, C. (2004) Distinct domains of the mu-opioid receptor control uncoupling and internalization. Mol. Pharmacol. 65, 528-537
45. Jin, W., Brown, S., Roche, J. P., Hsieh, C., Celver, J. P., Kovoor, A., Chavkin, C., and Mackie, K. (1999) Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J. Neurosci. 19, 3773-3780
46. Gärtner, F., Seidel, T., Schulz, U., Gummert, J., and Milting, H. (2013) Desensitization and internalization of endothelin receptor A: impact of G protein-coupled receptor kinase 2 (GRK2)-mediated phosphorylation. J. Biol. Chem. 288, 32138-32148
47. Ouedraogo, M., Lecat, S., Rochdi, M. D., Hachet-Haas, M., Matthes, H., Gicquiaux, H., Verrier, S., Gaire, M., Glasser, N., Mély, Y., Takeda, K., Bouvier, M., Galzi, J. L., and Bucher, B. (2008) Distinct motifs of neuropeptide Y receptors differentially regulate trafficking and desensitization. Traffic 9, 305-324
48. Butcher, A. J., Hudson, B. D., Shimpukade, B., Alvarez-Curto, E., Prihandoko, R., Ulven, T., Milligan, G., and Tobin, A. B. (2014) Concomitant action of structural elements and receptor phosphorylation determines arrestin-3 interaction with the free fatty acid receptor FFA4. J. Biol. Chem. 289, 18451-18465
49. Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., and Christie, M. J. (2013) Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol. Rev. 65, 223-254
50. Shukla, A. K., Manglik, A., Kruse, A. C., Xiao, K., Reis, R. I., Tseng, W. C., Staus, D. P., Hilger, D., Uysal, S., Huang, L. Y., Paduch, M., Tripathi-Shukla, P., Koide, A., Koide, S., Weis, W. I., Kossiakoff, A. A., Kobilka, B. K., and Lefkowitz, R. J. (2013) Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Nature 497, 137-141